We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Glyburide Advantage in Malignant Edema and Stroke - Remedy Pharmaceuticals (GAMES-RP)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01794182
Recruitment Status : Unknown
Verified May 2015 by Remedy Pharmaceuticals, Inc..
Recruitment status was:  Active, not recruiting
First Posted : February 18, 2013
Last Update Posted : June 2, 2015
Information provided by (Responsible Party):
Remedy Pharmaceuticals, Inc.